Quantamental Technologies’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,137
Closed -$279K 396
2021
Q4
$279K Buy
+6,137
New +$320K 0.14% 268
2019
Q4
Sell
-3,400
Closed -$77K 567
2019
Q3
$77K Buy
3,400
+3,200
+1,600% +$88.6K 0.03% 827
2019
Q2
$7K Buy
+200
New +$6.4K ﹤0.01% 1295

Other funds holding CDNA

Quantamental Technologies's CDNA Position: Q1 2022 in Review

Quantamental Technologies sold out of CareDx (CDNA) in Q1 2022, closing a stake of 6,137 shares — an estimated $279K sold.

Quantamental Technologies first reported a position in CDNA in Q2 2019 and held it in 3 quarters. The position peaked at $279K in Q4 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Quantamental Technologies reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Quantamental Technologies sold 6,137 CareDx shares in Q1 2022, an estimated $279K.
  • Quantamental Technologies first reported a position in CareDx in Q2 2019 and held it in 3 quarters.
  • Quantamental Technologies's CareDx position peaked at $279K in Q4 2021.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Quantamental Technologies's 13F filing for Q1 2022, filed 16 May 2022.